{"id":171891,"date":"2021-08-26T08:41:54","date_gmt":"2021-08-26T15:41:54","guid":{"rendered":"https:\/\/lifesciences.csoftintl.com\/?p=171891"},"modified":"2022-04-07T03:32:42","modified_gmt":"2022-04-07T10:32:42","slug":"%e6%8b%89%e7%be%8e%e7%b3%bb%e5%88%97%ef%bc%9a%e5%8c%bb%e7%96%97%e5%99%a8%e6%a2%b0%e4%bc%81%e4%b8%9a%e5%a6%82%e4%bd%95%e8%8e%b7%e5%be%97%e5%93%a5%e4%bc%a6%e6%af%94%e4%ba%9a%e5%b8%82%e5%9c%ba%e5%87%86","status":"publish","type":"post","link":"https:\/\/lifesciences.csoftintl.com\/zh-hans\/blog\/%e6%8b%89%e7%be%8e%e7%b3%bb%e5%88%97%ef%bc%9a%e5%8c%bb%e7%96%97%e5%99%a8%e6%a2%b0%e4%bc%81%e4%b8%9a%e5%a6%82%e4%bd%95%e8%8e%b7%e5%be%97%e5%93%a5%e4%bc%a6%e6%af%94%e4%ba%9a%e5%b8%82%e5%9c%ba%e5%87%86\/","title":{"rendered":"\u62c9\u7f8e\u7cfb\u5217\uff1a\u533b\u7597\u5668\u68b0\u4f01\u4e1a\u5982\u4f55\u83b7\u5f97\u54e5\u4f26\u6bd4\u4e9a\u5e02\u573a\u51c6\u5165"},"content":{"rendered":"

\u4e0a\u4e00\u7bc7\u62c9\u7f8e\u7cfb\u5217\u6211\u4eec\u4ecb\u7ecd\u4e86 <\/span>\u59d4\u5185\u745e\u62c9<\/span><\/a>, \u672c\u671f\u6211\u4eec\u5c06\u4e3a\u60a8\u4ecb\u7ecd\u54e5\u4f26\u6bd4\u4e9a\u7684\u533b\u7597\u5668\u68b0\u76d1\u7ba1\u9014\u5f84\u3002 <\/span>2018<\/span><\/a>\u5e74, \u54e5\u4f26\u6bd4\u4e9a\u533b\u7597\u5668\u68b0\u5e02\u573a\u8d85\u8fc780%\u4f9d\u8d56\u8fdb\u53e3\u8bbe\u5907\uff1b\u5e02\u503c\u7ea6 <\/span>$1.145 \u4ebf\u7f8e\u5143<\/span><\/a>\uff0c<\/span>\u672a\u6765\u8fd8\u5c06\u4fdd\u6301\u5f3a\u52b2\u7684\u589e\u957f\u8d8b\u52bf\u3002\u5bf9\u4e8e\u4f17\u591a\u533b\u7597\u5668\u68b0\u5236\u9020\u5546\u6765\u8bf4\uff0c\u4e86\u89e3\u54e5\u4f26\u6bd4\u4e9a\u7684\u533b\u7597\u5668\u68b0\u76d1\u7ba1\u89c4\u5219\u662f\u83b7\u5f97\u5e02\u573a\u51c6\u5165\uff0c\u5f00\u62d3\u5e02\u573a\u7684\u91cd\u8981\u6761\u4ef6\u3002<\/p>\n

\u00a0<\/span><\/p>\n

\u54e5\u4f26\u6bd4\u4e9a\u7684\u533b\u7597\u5668\u68b0\u76d1\u7ba1\u673a\u6784<\/span>\u00a0<\/span><\/h2>\n

\u5728\u54e5\u4f26\u6bd4\u4e9a\uff0c\u76d1\u7763\u533b\u7597\u5668\u68b0\u7684\u76d1\u7ba1\u673a\u6784\u88ab\u79f0\u4e3a\u56fd\u5bb6\u836f\u54c1\u548c\u98df\u54c1\u76d1\u7763\u5c40 (<\/span><\/b>INVIMA<\/span><\/b><\/a>)\u3002<\/span><\/b> \u8be5\u673a\u6784\u7531\u54e5\u4f26\u6bd4\u4e9a\u536b\u751f\u90e8\uff08MoH\uff09\u8bbe\u7acb\uff0c\u4e0d\u4ec5\u5305\u62ec\u533b\u7597\u5668\u68b0\u7684\u76d1\u7763\uff0c\u800c\u4e14\u8fd8\u5305\u542b\u4e86\u98df\u54c1\u3001\u836f\u54c1\u548c\u5176\u4ed6\u4efb\u4f55\u9700\u8981\u8fdb\u884c\u536b\u751f\u76d1\u7763\u7684\u4ea7\u54c1\u3002<\/span><\/p>\n

\u54e5\u4f26\u6bd4\u4e9a\u7684\u533b\u7597\u5668\u68b0\u76d1\u7ba1\u9014\u5f84<\/span>\u00a0<\/span><\/h2>\n

INVIMA \u5c06\u533b\u7597\u5668\u68b0<\/span>\u5b9a\u4e49\u4e3a<\/span>\u201c \u6240\u6709\u4eea\u5668\u3001\u88c5\u7f6e\u3001\u673a\u5668\u3001\u8f6f\u4ef6\u6216\u5176\u4ed6\u7c7b\u4f3c\u6216\u76f8\u5173\u7684\u751f\u7269\u533b\u5b66\u8bbe\u5907\uff0c\u65e0\u8bba\u662f\u5355\u72ec\u4f7f\u7528\u8fd8\u662f\u7ec4\u5408\u4f7f\u7528\uff0c\u5305\u62ec\u7528\u4e8e\u8bca\u65ad\u3001\u9884\u9632\u3001\u76d1\u6d4b\u3001\u6cbb\u7597\u6216\u51cf\u8f7b\u75be\u75c5\u6216\u4f24\u5bb3\u6240\u9700\u7684\u90e8\u4ef6\u3001\u914d\u4ef6\u548c\u8f6f\u4ef6\u5236\u9020\u5546\u3002\u8be5\u5b9a\u4e49\u8fd8\u6db5\u76d6\u5176\u4ed6\u6709\u52a9\u4e8e\u8bca\u65ad\u6216\u62a4\u7406\u6000\u5b55\u4ee5\u53ca\u4ea7\u540e\u6062\u590d\u7684\u8bbe\u5907\u548c\u7528\u4e8e\u8eab\u4f53\u673a\u80fd\u7684\u7814\u7a76\u3001\u4fee\u6539\u3001\u652f\u6301\u6216\u66ff\u6362\u4ee5\u53ca\u6240\u6709\u7528\u4e8e\u8bbe\u5907\u6d88\u6bd2\u6216\u706d\u83cc\u7684\u4ea7\u54c1\u3002<\/span><\/p>\n

\u533b\u7597\u5668\u68b0\u7684\u5206\u7c7b\u6982\u8ff0\u5982\u4e0b\uff1a<\/p>\n\n\n\n\n\n\n\n
\u7c7b\u522b<\/td>\n\u98ce\u9669\u7b49\u7ea7<\/td>\n\u793a\u4f8b<\/td>\n\u65f6\u957f<\/td>\n<\/tr>\n
I\u7c7b<\/td>\n\u4f4e<\/td>\n\u7ef7\u5e26\u3001\u542c\u8bca\u5668<\/td>\n1\u4e2a\u6708\u4ee5\u5185*<\/td>\n<\/tr>\n
IIa\u7c7b<\/td>\n\u4e2d\u4f4e<\/td>\n\u598a\u5a20\u6d4b\u8bd5\u4eea\uff0c\u52a9\u542c\u5668<\/td>\n1\u4e2a\u6708\u4ee5\u5185*<\/td>\n<\/tr>\n
IIb\u7c7b<\/td>\n\u4e2d\u9ad8<\/td>\n\u6ce8\u5c04\u5668\u3001\u9690\u5f62\u773c\u955c<\/td>\n6\u4e2a\u6708\u4ee5\u4e0a<\/td>\n<\/tr>\n
III\u7c7b<\/td>\n\u9ad8<\/td>\n\u5fc3\u810f\u8d77\u640f\u5668\u3001\u547c\u5438\u673a<\/td>\n6\u4e2a\u6708\u4ee5\u4e0a<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

*INVIMA \u4f1a\u81ea\u52a8\u6279\u51c6I \u7c7b\u548c IIa \u7c7b\u5668\u68b0\u7684\u7533\u8bf7\uff0c\u4f46INVIMA \u53ef\u80fd\u4f1a\u8981\u6c42\u7533\u62a5\u65b9\u5728 30 \u5929\u5185\u63d0\u4ea4\u5176\u4ed6\u6587\u4ef6\uff0c\u5426\u5219\u53ef\u80fd\u4f1a\u53d6\u6d88\u6279\u51c6\u3002<\/span><\/p>\n